Novel pharmacological therapies for irritable bowel syndrome

被引：19

作者：

Corsetti, Maura ^{[1
]}

Whorwell, Peter ^{[2
]}

机构：

[1] Univ Leuven, Translat Res Ctr Gastrointestinal Disorders TARGI, Leuven, Belgium

[2] Univ Manchester, Ctr Gastrointestinal Sci, Manchester, Lancs, England

来源：

EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY | 2016年 / 10卷 / 07期

关键词：

IBS treatment; pain; diarrhea; constipation; PLACEBO-CONTROLLED TRIAL; CHRONIC IDIOPATHIC CONSTIPATION; QUALITY-OF-LIFE; VISCERAL HYPERSENSITIVITY; REDUCES SYMPTOMS; ABDOMINAL-PAIN; DOUBLE-BLIND; DIARRHEA; SAFETY; LINACLOTIDE;

D O I：

10.1586/17474124.2016.1158099

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

Irritable bowel syndrome (IBS) is a prevalent functional gastrointestinal disorder, which represents a major cost to healthcare services. Current pharmacological treatment includes fibre supplements, antispasmodics, laxatives, loperamide and antidepressants. This article reviews the novel pharmacological treatments already or recently approved for patients with IBS-C (lubiprostone, linaclotide) and IBSD (alosetron, ramosetron, rifaximin, eluxadoline). Furthermore, results for drugs in development (plecanatide, ibudutant and ebastine) or used in chronic constipation or for other indications, with potential application in IBS (prucalopride, elobixibat, mesalazine, ondansetron and colesevelam) are also reviewed.

引用

页码：807 / 815

页数：9

共 69 条

[1] Screening for bile acid diarrhoea in suspected irritable bowel syndrome [J].

Aziz, Imran ;

Kurien, Matthew ;

Sanders, David S. ;

Ford, Alexander C. .

GUT, 2015, 64 (05) :851-851

[2] Randomised controlled trial of mesalazine in IBS [J].

Barbara, Giovanni ;

Cremon, Cesare ;

Annese, Vito ;

Basilisco, Guido ;

Bazzoli, Franco ;

Bellini, Massimo ;

Benedetti, Antonio ;

Benini, Luigi ;

Bossa, Fabrizio ;

Buldrini, Paola ;

Cicala, Michele ;

Cuomo, Rosario ;

Germana, Bastianello ;

Molteni, Paola ;

Neri, Matteo ;

Rodi, Marcello ;

Saggioro, Alfredo ;

Scribano, Maria Lia ;

Vecchi, Maurizio ;

Zoli, Giorgio ;

Corinaldesi, Roberto ;

Stanghellini, Vincenzo .

GUT, 2016, 65 (01) :82-90

[3] Linaclotide for treatment of irritable bowel syndrome-The view of European regulators [J].

Berntgen, Michael ;

Enzmann, Harald ;

Schabel, Elmer ;

Prieto Yerro, Concepcion ;

Gomez-Outes, Antonio ;

Salmonson, Tomas ;

Musaus, Joachim .

DIGESTIVE AND LIVER DISEASE, 2013, 45 (09) :724-726

[4] Activation of Intestinal Cl- Secretion by Lubiprostone Requires the Cystic Fibrosis Transmembrane Conductance Regulator [J].

Bijvelds, Marcel J. C. ;

Bot, Alice G. M. ;

Escher, Johanna C. ;

de Jonge, Hugo R. .

GASTROENTEROLOGY, 2009, 137 (03) :976-985

[5] Pharmacologic Properties, Metabolism, and Disposition of Linaclotide, a Novel Therapeutic Peptide Approved for the Treatment of Irritable Bowel Syndrome with Constipation and Chronic Idiopathic Constipation [J].

Busby, Robert W. ;

Kessler, Marco M. ;

Bartolini, Wilmin P. ;

Bryant, Alexander P. ;

Hannig, Gerhard ;

Higgins, Carolyn S. ;

Solinga, Robert M. ;

Tobin, Jenny V. ;

Wakefield, James D. ;

Kurtz, Caroline B. ;

Currie, Mark G. .

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2013, 344 (01) :196-206

[6] Efficacy and safety of alosetron in women with irritable bowel syndrome: a randomised, placebo-controlled trial [J].

Camilleri, M ;

Northcutt, AR ;

Kong, S ;

Dukes, GE ;

McSorley, D ;

Mangel, AW .

LANCET, 2000, 355 (9209) :1035-1040

[7] Effect of colesevelam on faecal bile acids and bowel functions in diarrhoea-predominant irritable bowel syndrome [J].

Camilleri, M. ;

Acosta, A. ;

Busciglio, I. ;

Boldingh, A. ;

Dyer, R. B. ;

Zinsmeister, A. R. ;

Lueke, A. ;

Gray, A. ;

Donato, L. J. .

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2015, 41 (05) :438-448

[8] A placebo-controlled trial of prucalopride for severe chronic constipation [J].

Camilleri, Michael ;

Kerstens, Rene ;

Rykx, An ;

Vandeplassche, Lieve .

NEW ENGLAND JOURNAL OF MEDICINE, 2008, 358 (22) :2344-2354

[9] Evaluation of Alosetron Using the New FDA Composite Endpoint Demonstrates Strong Treatment Effect in Females With Severe Irritable Bowel Syndrome With Diarrhea [J].

Camilleri, Michael ;

Krause, Richard ;

Deveze, Sandy ;

Rao, Tharak ;

Earnest, David .

AMERICAN JOURNAL OF GASTROENTEROLOGY, 2014, 109 :S535-S535

[10] Irritable Bowel Syndrome: Methods, Mechanisms, and Pathophysiology. The confluence of increased permeability, inflammation, and pain in irritable bowel syndrome [J].

Camilleri, Michael ;

Lasch, Karen ;

Zhou, Wen .

AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 2012, 303 (07) :G775-G785

← 1 2 3 4 5 6 7 →